These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 37485772)
1. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain. Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772 [TBL] [Abstract][Full Text] [Related]
2. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
3. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies. Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200 [TBL] [Abstract][Full Text] [Related]
4. FKBP12-immunopositive inclusions in patients with α-synucleinopathies. Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765 [TBL] [Abstract][Full Text] [Related]
5. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy. Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825 [TBL] [Abstract][Full Text] [Related]
6. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential. Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics. Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy. Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610 [TBL] [Abstract][Full Text] [Related]
9. Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions. De Giorgi F; Abdul-Shukkoor MB; Kashyrina M; Largitte LA; De Nuccio F; Kauffmann B; Lends A; Laferrière F; Bonhommeau S; Lofrumento DD; Bousset L; Bezard E; Buffeteau T; Loquet A; Ichas F Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327628 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy. Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F Cells; 2020 Oct; 9(11):. PubMed ID: 33138150 [TBL] [Abstract][Full Text] [Related]
11. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy. Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology. Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088 [TBL] [Abstract][Full Text] [Related]
13. Electron Microscopic Analysis of α-Synuclein Fibrils. Tarutani A; Hasegawa M Methods Mol Biol; 2021; 2322():17-25. PubMed ID: 34043188 [TBL] [Abstract][Full Text] [Related]
14. Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein. Frieg B; Geraets JA; Strohäker T; Dienemann C; Mavroeidi P; Jung BC; Kim WS; Lee SJ; Xilouri M; Zweckstetter M; Schröder GF Commun Biol; 2022 Sep; 5(1):1040. PubMed ID: 36180728 [TBL] [Abstract][Full Text] [Related]
15. GV-971 attenuates α-Synuclein aggregation and related pathology. Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy. Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095 [TBL] [Abstract][Full Text] [Related]
17. Is Multiple System Atrophy a Prion-like Disorder? Jellinger KA; Wenning GK; Stefanova N Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255 [TBL] [Abstract][Full Text] [Related]
18. Progression of phosphorylated α-synuclein in Macaca fuscata. Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430 [TBL] [Abstract][Full Text] [Related]
19. Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy. Luo H; Yu X; Li P; Hu J; Li W; Li X; Chen M; Yu S Neuroscience; 2024 Oct; 557():1-11. PubMed ID: 39127345 [TBL] [Abstract][Full Text] [Related]
20. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Ghanem SS; Majbour NK; Vaikath NN; Ardah MT; Erskine D; Jensen NM; Fayyad M; Sudhakaran IP; Vasili E; Melachroinou K; Abdi IY; Poggiolini I; Santos P; Dorn A; Carloni P; Vekrellis K; Attems J; McKeith I; Outeiro TF; Jensen PH; El-Agnaf OMA Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109617119. PubMed ID: 35353605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]